The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Regulatory T cells (Tregs) that express the transcription factor Foxp3 are critical for regulating intestinal inflammation. Candidate microbe approaches have identified bacterial species and strain-specific molecules that can affect intestinal immune responses, including species that modulate Treg responses. Because neither all humans nor mice harbor the same bacterial strains, we posited that more prevalent factors exist that regulate the number and function of colonic Tregs. We determined that short-chain fatty acids, gut microbiota-derived bacterial fermentation products, regulate the size and function of the colonic Treg pool and protect against colitis in a Ffar2-dependent manner in mice. Our study reveals that a class of abundant microbial metabolites underlies adaptive immune microbiota coadaptation and promotes colonic homeostasis and health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“acetate and propionate, but not butyrate, stimulate the expansion of pre-existing colonic Tregs (cTregs)”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Smith et al., 2013
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“and on DCs, conferring a higher capacity to drive naïve T cell differentiation into Tregs [38-40].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [40]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“SCFAs promote the development of naive CD4+ T cells into regulatory T cells (31, 32), induce “tolerogenic” dendritic cells in the intestinal mucosa (33), and limit autoimmity (34, 35).”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [31]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs serve as ligands for GPR41 and GPR43 on intestinal Tregs and epithelial cells, leading to activation mitogen-activated protein kinase signaling and secretion of chemokines and cytokines11,40.”
From Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer (2021) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCFAs have context-dependent functions: they can promote the expansion of Treg cells and also improve effector T cell functions133–136.”
From Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy (2023) · cites this paper as [134]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“While the gut microbiota composition is divergent across individuals, functional gene profiles are quite similar (24, 25), and alterations to common gut microbial metabolic pathways may affect production of symbiotic factors, such as SCFA, which regulate intestinal adaptive immune responses and promote health.”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 1×
“The western dietary pattern, specifically reduced ingestion of plant-based fibers, may be a critical factor that links the gut microbiome to disease (23).”
BackgroundDiversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533 · cited 1×
“Gut microbiota-host immune misadaptation has been implicated in the rising incidence of IBD, other inflammatory diseases, and obesity (22).”
BackgroundInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“Disruption of this homeostasis leads to intestinal inflammation and disease (2, 3).”
BackgroundInduction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752 · cited 4×
“The antibiotic vancomycin, which targets Gram-positive bacteria and disrupts the gut microbiota (12), reduces cTregs to similar levels as observed in GF mice (7) (fig.”
BackgroundInfluentialEcological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“Humans and mice rely on bacteria to breakdown undigestible dietary components, such as fibers (8).”
BackgroundRegulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Short chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119 · cited 2×
“In SPF mice, SCFA are taken up by colonic epithelial cells but also diffuse through the epithelium into the lamina propria where they can mediate their effects directly (9, 14).”
BackgroundBifidobacteria can protect from enteropathogenic infection through production of acetate
Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J. M., Topping, D. L., Suzuki, T., et al. (2011) · Nature · doi:10.1038/nature09646 · Cited by 2,387 · cited 1×
“These results may explain the benefits of dietary fibers and bacteria, such as clostridia and bifidobacteria (13) that can increase colonic luminal SCFA production and modulate inflammation in mice and humans.”
Background
Cited by
Items 401–500 of 1,070
The gut microbiome and hypertension
O’Donnell, J. A., Zheng, T., Meric, G., & Marques, F. Z. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00654-0 · Cited by 281
Lipid metabolism in T cell signaling and function
Lim, S. A., Su, W., Chapman, N. M., & Chi, H. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01017-3 · Cited by 278
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Newell, P. D., & Douglas, A. E. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.02742-13 · Cited by 280
Park, J.-H., Kotani, T., Konno, T., Setiawan, J., Kitamura, Y., Imada, S., Usui, Y., Hatano, N., Shinohara, M., Saito, Y., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0156334 · Cited by 278
Therapeutic potential of ectopic olfactory and taste receptors
Lee, S.-J., Depoortere, I., & Hatt, H. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0002-3 · Cited by 279
Secretory IgA in Intestinal Mucosal Secretions as an Adaptive Barrier against Microbial Cells
Pietrzak, B., Tomela, K., Olejnik-Schmidt, A., Mackiewicz, A., & Schmidt, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239254 · Cited by 276
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
Meijnikman, A. S., Gerdes, V. E., Nieuwdorp, M., & Herrema, H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00192 · Cited by 278
Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study
Racine, A., Carbonnel, F., Chan, S. S. M., Hart, A. R., Bueno-de-Mesquita, H. B., Oldenburg, B., van Schaik, F. D. M., Tjønneland, A., Olsen, A., Dahm, C. C., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000638 · Cited by 276
Unique aspects of the perinatal immune system
Zhang, X., Zhivaki, D., & Lo-Man, R. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.54 · Cited by 276
Metabolic control of regulatory T cell development and function
Zeng, H., & Chi, H. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.08.003 · Cited by 274
The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease
Zhu, H., Cao, C., Wu, Z., Zhang, H., Sun, Z., Wang, M., Xu, H., Zhao, Z., Wang, Y., Pei, G., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.06.014 · Cited by 274
Vaziri, N. D., Liu, S.-M., Lau, W. L., Khazaeli, M., Nazertehrani, S., Farzaneh, S. H., Kieffer, D. A., Adams, S. H., & Martin, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114881 · Cited by 274
The Role of Probiotics and Prebiotics in Inducing Gut Immunity
Vieira, A. T., Teixeira, M. M., & Martins, F. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00445 · Cited by 273
Dupraz, L., Magniez, A., Rolhion, N., Richard, M. L., Da Costa, G., Touch, S., Mayeur, C., Planchais, J., Agus, A., Danne, C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109332 · Cited by 274
Bacteroides utilization for dietary polysaccharides and their beneficial effects on gut health
Cheng, J., Hu, J., Geng, F., & Nie, S. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.04.002 · Cited by 268
Kang, C., Wang, B., Kaliannan, K., Wang, X., Lang, H., Hui, S., Huang, L., Zhang, Y., Zhou, M., Chen, M., et al. (2017) · mBio · doi:10.1128/mbio.00470-17 · Cited by 272
Miyamoto, J., Mizukure, T., Park, S.-B., Kishino, S., Kimura, I., Hirano, K., Bergamo, P., Rossi, M., Suzuki, T., Arita, M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610733 · Cited by 272
Chronic kidney disease and the gut microbiome
Hobby, G. P., Karaduta, O., Dusio, G. F., Singh, M., Zybailov, B. L., & Arthur, J. M. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00298.2018 · Cited by 267
Pellegrini, C., Antonioli, L., Colucci, R., Blandizzi, C., & Fornai, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1856-5 · Cited by 270
“PD Bacteroidetes (conflicting evidence) = Firmicutes (conflicting evidence) Blautia, Coprococcus, Roseburia, Escherichia coli, Akkermansia, Bifidobacterium, Flavonifractor and Lactobacillus, Christensenella, Catabacter, Oscillospira, Christensenella minuta, Catabacter hongkongensis, Lactobacillus mucosae, Ruminococcus…”
BackgroundAccounting for reciprocal host–microbiome interactions in experimental science
Stappenbeck, T. S., & Virgin, H. W. (2016) · Nature · doi:10.1038/nature18285 · Cited by 270
Complex Pharmacology of Free Fatty Acid Receptors
Milligan, G., Shimpukade, B., Ulven, T., & Hudson, B. D. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00056 · Cited by 267
Adaptive immune education by gut microbiota antigens
Zhao, Q., & Elson, C. O. (2018) · Immunology · doi:10.1111/imm.12896 · Cited by 268
Beyond Host Defense: Emerging Functions of the Immune System in Regulating Complex Tissue Physiology
Rankin, L. C., & Artis, D. (2018) · Cell · doi:10.1016/j.cell.2018.03.013 · Cited by 269
Regulation of the Immune System by the Resident Intestinal Bacteria
Kamada, N., & Núñez, G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.060 · Cited by 269
Interplay between food and gut microbiota in health and disease
Danneskiold-Samsøe, N. B., Dias de Freitas Queiroz Barros, H., Santos, R., Bicas, J. L., Cazarin, C. B. B., Madsen, L., Kristiansen, K., Pastore, G. M., Brix, S., & Maróstica Júnior, M. R. (2019) · Food Research International · doi:10.1016/j.foodres.2018.07.043 · Cited by 268
The liver–brain–gut neural arc maintains the Treg cell niche in the gut
Teratani, T., Mikami, Y., Nakamoto, N., Suzuki, T., Harada, Y., Okabayashi, K., Hagihara, Y., Taniki, N., Kohno, K., Shibata, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2425-3 · Cited by 267
The Pharmacology and Function of Receptors for Short-Chain Fatty Acids
Bolognini, D., Tobin, A. B., Milligan, G., & Hodge, D. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.102301 · Cited by 267
Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer
Bultman, S. J. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500902 · Cited by 265
Alteration of the gut microbiota in Chinese population with chronic kidney disease
Jiang, S., Xie, S., Lv, D., Wang, P., He, H., Zhang, T., Zhou, Y., Lin, Q., Zhou, H., Jiang, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02989-2 · Cited by 266
Vemuri, R., Sylvia, K. E., Klein, S. L., Forster, S. C., Plebanski, M., Eri, R., & Flanagan, K. L. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-018-0716-7 · Cited by 265
Hou, H., Chen, D., Zhang, K., Zhang, W., Liu, T., Wang, S., Dai, X., Wang, B., Zhong, W., & Cao, H. (2022) · Cancer Letters · doi:10.1016/j.canlet.2021.11.027 · Cited by 263
Han, Y., Wang, B., Gao, H., He, C., Hua, R., Liang, C., Zhang, S., Wang, Y., Xin, S., & Xu, J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s384949 · Cited by 265
Alterations of the Host Microbiome Affect Behavioral Responses to Cocaine
Kiraly, D. D., Walker, D. M., Calipari, E. S., Labonte, B., Issler, O., Pena, C. J., Ribeiro, E. A., Russo, S. J., & Nestler, E. J. (2016) · Scientific Reports · doi:10.1038/srep35455 · Cited by 264
The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases
Zhang, S., Gang, X., Yang, S., Cui, M., Sun, L., Li, Z., & Wang, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678355 · Cited by 263
Tordesillas, L., & Berin, M. C. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8680-5 · Cited by 262
Antibiotics in early life: dysbiosis and the damage done
Neuman, H., Forsythe, P., Uzan, A., Avni, O., & Koren, O. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy018 · Cited by 259
Pernomian, L., Duarte-Silva, M., & de Barros Cardoso, C. R. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08789-3 · Cited by 258
Reynolds, L. A., Smith, K. A., Filbey, K. J., Harcus, Y., Hewitson, J. P., Redpath, S. A., Valdez, Y., Yebra, M. J., Finlay, B. B., & Maizels, R. M. (2014) · Gut Microbes · doi:10.4161/gmic.32155 · Cited by 258
Osteoporosis: Pathophysiology and therapeutic options
Föger‐Samwald, U., Dovjak, P., Azizi-Semrad, U., Kerschan‐Schindl, K., & Pietschmann, P. (2020) · EXCLI journal · doi:10.17179/excli2020-2591 · Cited by 257
Coker, O. O., Liu, C., Wu, W. K. K., Wong, S. H., Jia, W., Sung, J. J. Y., & Yu, J. (2022) · Microbiome · doi:10.1186/s40168-021-01208-5 · Cited by 255
Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity
Yamamoto, E. A., & Jørgensen, T. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03141 · Cited by 256
The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages
Wang, J., Chen, W.-D., & Wang, Y.-D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01065 · Cited by 253
Targeting T cell metabolism for therapy
O'Sullivan, D., & Pearce, E. L. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.004 · Cited by 254
Nylund, L., Nermes, M., Isolauri, E., Salminen, S., de Vos, W. M., & Satokari, R. (2015) · Allergy · doi:10.1111/all.12549 · Cited by 254
Interplay between the lung microbiome and lung cancer
Mao, Q., Jiang, F., Yin, R., Wang, J., Xia, W., Dong, G., Ma, W., Yang, Y., Xu, L., & Hu, J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.11.036 · Cited by 254
Early life microbial exposures and allergy risks: opportunities for prevention
Renz, H., & Skevaki, C. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00420-y · Cited by 254
Richards, J. L., Yap, Y. A., McLeod, K. H., Mackay, C. R., & Mariño, E. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.29 · Cited by 250
The impact of diet on asthma and allergic diseases
Julia, V., Macia, L., & Dombrowicz, D. (2015) · Nature Reviews Immunology · doi:10.1038/nri3830 · Cited by 253
Dutzan, N., Abusleme, L., Bridgeman, H., Greenwell-Wild, T., Zangerle-Murray, T., Fife, M. E., Bouladoux, N., Linley, H., Brenchley, L., Wemyss, K., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.010 · Cited by 252
“This is particularly true in the gastrointestinal (GI) tract and skin, where tissue-specific and microbial-derived signals have been shown to shape the immune surveillance network and immune responsiveness (Ivanov et al., 2009; Naik et al., 2012; Smith et al., 2013).”
BackgroundInfluentialTian, P., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.007 · Cited by 251
Zhang, Z., Tang, H., Chen, P., Xie, H., & Tao, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0074-5 · Cited by 251
Lung Homeostasis: Influence of Age, Microbes, and the Immune System
Lloyd, C. M., & Marsland, B. J. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.005 · Cited by 251
Zhang, S., Langer, R., & Traverso, G. (2017) · Nano Today · doi:10.1016/j.nantod.2017.08.006 · Cited by 250
Implications of the Westernized Diet in the Onset and Progression of IBD
Rizzello, F., Spisni, E., Giovanardi, E., Imbesi, V., Salice, M., Alvisi, P., Valerii, M. C., & Gionchetti, P. (2019) · Nutrients · doi:10.3390/nu11051033 · Cited by 250
Linking the Microbiota, Chronic Disease, and the Immune System
Hand, T. W., Vujkovic-Cvijin, I., Ridaura, V. K., & Belkaid, Y. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.08.003 · Cited by 247
The microbiota in inflammatory bowel disease
Sheehan, D., Moran, C., & Shanahan, F. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1064-1 · Cited by 246
Tissue adaptation of regulatory and intraepithelial CD4 + T cells controls gut inflammation
Sujino, T., London, M., Hoytema van Konijnenburg, D. P., Rendon, T., Buch, T., Silva, H. M., Lafaille, J. J., Reis, B. S., & Mucida, D. (2016) · Science · doi:10.1126/science.aaf3892 · Cited by 250
Mishima, E., Fukuda, S., Mukawa, C., Yuri, A., Kanemitsu, Y., Matsumoto, Y., Akiyama, Y., Fukuda, N. N., Tsukamoto, H., Asaji, K., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.011 · Cited by 250
Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities
Iliev, I. D., Ananthakrishnan, A. N., & Guo, C.-J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01163-0 · Cited by 249
“Previous research demonstrated that propionic and butyric acids contribute to colonic and peripheral T reg cell differentiation in mouse intestines through activation of the GPR43 fatty acid receptor 111,112 .”
A comprehensive framework for early-onset colorectal cancer research
Eng, C., Jácome, A. A., Agarwal, R., Hayat, M. H., Byndloss, M. X., Holowatyj, A. N., Bailey, C., & Lieu, C. H. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00588-x · Cited by 241
Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model
Hryckowian, A. J., Van Treuren, W., Smits, S. A., Davis, N. M., Gardner, J. O., Bouley, D. M., & Sonnenburg, J. L. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0150-6 · Cited by 248
“The cocktail of SCFAs that we used was previously shown to affect SCFA levels in the cecal contents and feces of germ free mice 32,33 .”
Nagao-Kitamoto, H., Shreiner, A. B., Gillilland, M. G., Kitamoto, S., Ishii, C., Hirayama, A., Kuffa, P., El-Zaatari, M., Grasberger, H., Seekatz, A. M., et al. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.02.003 · Cited by 248
Shi, H., Ge, X., Ma, X., Zheng, M., Cui, X., Pan, W., Zheng, P., Yang, X., Zhang, P., Hu, M., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01172-0 · Cited by 247
Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases
Li, Y., Tang, R., Leung, P. S. C., Gershwin, M. E., & Ma, X. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.002 · Cited by 247
Novel players in coeliac disease pathogenesis: role of the gut microbiota
Verdu, E. F., Galipeau, H. J., & Jabri, B. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.90 · Cited by 247
Gut Mycobiota in Immunity and Inflammatory Disease
Li, X. V., Leonardi, I., & Iliev, I. D. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.023 · Cited by 246
“Bacterial metabolites activate G protein-coupled receptors (GPCRs) and inhibit histone deacetylases (HDACs) to modulate both host immunity as well as other members of the intestinal microbiota (Chang et al., 2014; Morita et al., 2019; Smith et al., 2013).”
BackgroundCrosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy
Campbell, C., Kandalgaonkar, M. R., Golonka, R. M., Yeoh, B. S., Vijay-Kumar, M., & Saha, P. (2023) · Biomedicines · doi:10.3390/biomedicines11020294 · Cited by 243
Dietary Fibers from Fruits and Vegetables and Their Health Benefits via Modulation of Gut Microbiota
Cui, J., Lian, Y., Zhao, C., Du, H., Han, Y., Gao, W., Xiao, H., & Zheng, J. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12489 · Cited by 241
Biological significance of short-chain fatty acid metabolism by the intestinal microbiome
Puertollano, E., Kolida, S., & Yaqoob, P. (2014) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000025 · Cited by 244
Metabolism meets immunity: The role of free fatty acid receptors in the immune system
Alvarez-Curto, E., & Milligan, G. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.03.017 · Cited by 240
Cui, H., Cai, Y., Wang, L., Jia, B., Li, J., Zhao, S., Chu, X., Lin, J., Zhang, X., Bian, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00571 · Cited by 240
Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer
Koliarakis, I., Messaritakis, I., Nikolouzakis, T. K., Hamilos, G., Souglakos, J., & Tsiaoussis, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174146 · Cited by 242
“However, similar SCFA production in the colon following fermentation of dietary fibers by commensal bacteria is beneficial, mediating colonic homeostasis [157].”
BackgroundZhang, W., Xu, J.-H., Yu, T., & Chen, Q.-K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109131 · Cited by 242
RetractedMicrobiota Metabolites in Health and Disease
McCarville, J. L., Chen, G. Y., Cuevas, V. D., Troha, K., & Ayres, J. S. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-071219-125715 · Cited by 241
A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Yang, Q., Wang, B., Zheng, Q., Li, H., Meng, X., Zhou, F., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202207366 · Cited by 240
Emerging roles of the microbiome in cancer
Bultman, S. J. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt392 · Cited by 239
Impacts of microbiome metabolites on immune regulation and autoimmunity
Haase, S., Haghikia, A., Wilck, N., Müller, D. N., & Linker, R. A. (2018) · Immunology · doi:10.1111/imm.12933 · Cited by 239
Microbiota-mediated inflammation and antimicrobial defense in the intestine
Caballero, S., & Pamer, E. G. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120238 · Cited by 238
Zheng, M., Han, R., Yuan, Y., Xing, Y., Zhang, W., Sun, Z., Liu, Y., Li, J., & Mao, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1089600 · Cited by 241
Mucus sialylation determines intestinal host-commensal homeostasis
Yao, Y., Kim, G., Shafer, S., Chen, Z., Kubo, S., Ji, Y., Luo, J., Yang, W., Perner, S. P., Kanellopoulou, C., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.013 · Cited by 237
Host- and Microbiota-Derived Extracellular Vesicles, Immune Function, and Disease Development
Macia, L., Nanan, R., Hosseini-Beheshti, E., & Grau, G. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010107 · Cited by 237
“While initially they were only considered as bacterial waste products, it is now established that SCFAs play a key role in the differentiation and function of most immune cells including anti-inflammatory regulatory T cells (Treg) [84,85], CD8+ T cells [86], macrophages [87,88], tolerogenic CD103+ dendritic cells [79,…”
BackgroundMetabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
Kerk, S. A., Papagiannakopoulos, T., Shah, Y. M., & Lyssiotis, C. A. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00375-9 · Cited by 237
Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa
Pandiyan, P., Bhaskaran, N., Zou, M., Schneider, E., Jayaraman, S., & Huehn, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00426 · Cited by 236
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
Seo, D.-O., & Holtzman, D. M. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01146-2 · Cited by 230
Microbiota and the gut–brain axis
Bienenstock, J., Kunze, W., & Forsythe, P. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv019 · Cited by 234
Dynamic balancing of intestinal short-chain fatty acids: The crucial role of bacterial metabolism
Xu, Y., Zhu, Y., Li, X., & Sun, B. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.02.026 · Cited by 234
Short-Chain Fatty Acids, Maternal Microbiota and Metabolism in Pregnancy
Ziętek, M., Celewicz, Z., & Szczuko, M. (2021) · Nutrients · doi:10.3390/nu13041244 · Cited by 233
“The presence of GPR43 is demonstrated in adipose tissue [31,32], intestines [33,34] (regulatory T cells—Treg cells), other immune tissues [31,32] as well as in alpha and beta islet cells [35,36] and monocytes, neutrophils and eosinophils [32,37].”
BackgroundInulin fibre promotes microbiota-derived bile acids and type 2 inflammation
Arifuzzaman, M., Won, T. H., Li, T.-T., Yano, H., Digumarthi, S., Heras, A. F., Zhang, W., Parkhurst, C. N., Kashyap, S., Jin, W.-B., et al. (2022) · Nature · doi:10.1038/s41586-022-05380-y · Cited by 230
Wu, M., Tian, T., Mao, Q., Zou, T., Zhou, C.-J., Xie, J., & Chen, J.-J. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01038-3 · Cited by 232
Chen, L., Sun, M., Wu, W., Yang, W., Huang, X., Xiao, Y., Ma, C., Xu, L., Yao, S., Liu, Z., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz046 · Cited by 231
Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease
Cong, J., Zhou, P., & Zhang, R. (2022) · Nutrients · doi:10.3390/nu14091977 · Cited by 231
“SCFAs could protect mice against colitis by modulating colonic Treg number and activity in a GPR43-dependent manner [58], because GPR43-deficient (Gpr43(−/−)) mice showed unresolving or exacerbated inflammation in models of colitis [26].”
BackgroundThe dual role of short fatty acid chains in the pathogenesis of autoimmune disease models
Mizuno, M., Noto, D., Kaga, N., Chiba, A., & Miyake, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173032 · Cited by 230
The microbiota-immune axis as a central mediator of gut-brain communication
Fung, T. C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104714 · Cited by 230
Duan, H., Wang, L., Huangfu, M., & Li, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115276 · Cited by 226
Butyrate suppresses demyelination and enhances remyelination
Chen, T., Noto, D., Hoshino, Y., Mizuno, M., & Miyake, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1552-y · Cited by 229
The microbiome and autoimmunity: a paradigm from the gut–liver axis
Li, B., Selmi, C., Tang, R., Gershwin, M. E., & Ma, X. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2018.7 · Cited by 229
Vindigni, S. M., Zisman, T. L., Suskind, D. L., & Damman, C. J. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16644242 · Cited by 229
Truax, A. D., Chen, L., Tam, J. W., Cheng, N., Guo, H., Koblansky, A. A., Chou, W.-C., Wilson, J. E., Brickey, W. J., Petrucelli, A., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.08.009 · Cited by 228
“Since Lachnospiraceae produced SCFA and also mitigated obesity in Nlrp12-/- mice, we assessed if SCFA could limit HFD-induced obesity in the Nlrp12-/- mice.”
BackgroundInfluentialSpiljar, M., Merkler, D., & Trajkovski, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01353 · Cited by 219
Metadata
- Authors
- Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S.
- Affiliations
- Harvard University (US)
- AstraZeneca, RAD-Transgenic, Mölndal, Sweden.
- Broad Institute (US)
- Corresponding author
- Garrett, Wendy S.
- Venue
- Science
- Published
- 2013-08-02
- Volume
- 341
- Issue
- 6145
- Pages
- 569-573
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3807819
- OpenAlex
- W2060185417
- Cited by
- 5,413
- References
- 28
- Citations by year
- 2026: 483 · 2025: 507 · 2024: 556 · 2023: 551 · 2022: 497 · 2021: 560 · 2020: 452 · 2019: 403 · 2018: 344 · 2017: 319 · 2016: 276 · 2015: 226 · 2014: 204 · 2013: 31
- FWCI
- 109.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Cancer Institute (R01CA154426)
- National Institute of General Medical Sciences (R01GM099537)
- National Institute of Allergy and Infectious Diseases (K08AI078942)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK098826, F32DK095506, P30DK034854)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- regulatory T cells, Foxp3, short-chain fatty acids, gut microbiota, microbial metabolites, colitis, FFAR2, intestinal inflammation, bacterial fermentation products
- MeSH terms
- Animals, Bacteria, Colitis, Colon, DNA-Binding Proteins, Fatty Acids, Volatile, Fermentation, Germ-Free Life, Homeostasis, Humans, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, G-Protein-Coupled, T-Lymphocytes, Regulatory, Mice, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.